GRANDI, NICOLE
 Distribuzione geografica
Continente #
EU - Europa 82.197
NA - Nord America 2.363
AS - Asia 676
SA - Sud America 86
AF - Africa 11
OC - Oceania 8
Totale 85.341
Nazione #
IT - Italia 81.463
US - Stati Uniti d'America 2.348
SE - Svezia 313
CN - Cina 250
SG - Singapore 228
UA - Ucraina 134
DE - Germania 90
BR - Brasile 68
FI - Finlandia 62
VN - Vietnam 58
GB - Regno Unito 39
FR - Francia 31
HK - Hong Kong 31
KR - Corea 23
IN - India 15
CA - Canada 12
NL - Olanda 11
AR - Argentina 9
ID - Indonesia 9
AT - Austria 8
IR - Iran 8
JP - Giappone 8
RU - Federazione Russa 8
TR - Turchia 8
IE - Irlanda 7
IL - Israele 7
BE - Belgio 6
CZ - Repubblica Ceca 5
NZ - Nuova Zelanda 5
PT - Portogallo 5
EC - Ecuador 4
EG - Egitto 4
MA - Marocco 4
MY - Malesia 4
PK - Pakistan 4
AU - Australia 3
AZ - Azerbaigian 3
DK - Danimarca 3
IQ - Iraq 3
OM - Oman 3
PL - Polonia 3
QA - Qatar 3
BO - Bolivia 2
HR - Croazia 2
SK - Slovacchia (Repubblica Slovacca) 2
TH - Thailandia 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
BD - Bangladesh 1
BG - Bulgaria 1
CH - Svizzera 1
CO - Colombia 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
ES - Italia 1
KG - Kirghizistan 1
LK - Sri Lanka 1
NO - Norvegia 1
PA - Panama 1
PE - Perù 1
PH - Filippine 1
SD - Sudan 1
SI - Slovenia 1
TJ - Tagikistan 1
TW - Taiwan 1
UZ - Uzbekistan 1
VE - Venezuela 1
ZA - Sudafrica 1
Totale 85.341
Città #
Cagliari 78.639
Uta 2.574
Fairfield 352
Houston 204
Nyköping 182
Woodbridge 175
Ashburn 165
Boardman 144
Chandler 137
Seattle 122
Wilmington 121
Singapore 119
Cambridge 103
Ann Arbor 87
Dearborn 69
Jacksonville 69
Dong Ket 58
Santa Clara 51
New York 41
Helsinki 39
Shanghai 38
Beijing 36
Nanjing 31
Boston 27
Milan 26
San Diego 22
Siracusa 20
Bultei 18
Hong Kong 18
Seoul 16
Herndon 15
Redwood City 14
Los Angeles 11
Nanchang 11
Phoenix 11
Düsseldorf 10
Nuremberg 10
Sassari 10
Atlanta 9
Rome 9
Wuhan 9
Changsha 8
Frankfurt am Main 8
Toronto 8
Bhubaneswar 7
Bologna 7
Guangzhou 7
Jakarta 7
Jiaxing 7
Lappeenranta 7
Shenyang 7
Washington 7
Istanbul 6
Mountain View 6
Tokyo 6
Auckland 5
Borås 5
Geumjeong-gu 5
Norwalk 5
Redmond 5
San Martín de los Andes 5
The Dalles 5
Amsterdam 4
Brno 4
Brussels 4
Cosenza 4
Council Bluffs 4
Dublin 4
Falls Church 4
Hangzhou 4
Hebei 4
Jinan 4
London 4
Minneapolis 4
Munich 4
Baghdad 3
Baku 3
Belo Horizonte 3
Copenhagen 3
Covilha 3
Doha 3
Durham 3
Hefei 3
Millbury 3
Muscat 3
Ningbo 3
Shenzhen 3
Skerries 3
Southwark 3
São Paulo 3
Torino 3
Verona 3
Vienna 3
Angiari 2
Auby 2
Aversa 2
Baotou 2
Barking 2
Bengaluru 2
Brasília 2
Totale 84.075
Nome #
Sennoside A, derived from the traditional chinese medicine plant Rheum L., is a new dual HIV-1 inhibitor effective on HIV-1 replication 3.367
Inhibition of HIV-1 reverse transcriptase dimerization by small molecules 3.015
Novel natural non-nucleoside inhibitors of HIV-1 reverse transcriptase identified by shape- and structure-based virtual screening techniques 3.010
Structure-guided approach identifies a novel class of HIV-1 Ribonuclease H inhibitors: Binding mode insights through magnesium complexation and site-directed mutagenesis studies 2.848
From the traditional Chinese medicine plant Schisandra chinensis new scaffolds effective on HIV-1 reverse transcriptase resistant to non-nucleoside inhibitors 2.803
ANALYSIS OF 98 HERV-K(HML-2) CONTAINING PROVIRUSES IDENTIFIED IN THE HUMAN GENOME ASSEMBLY GRCH37/HG19 BY RETROTECTOR AND THEIR GENOMIC CONTEXT 2.630
Identification of a novel HERV-K(HML10): comprehensive characterization and comparative analysis in non-human primates provide insights about HML10 proviruses structure and diffusion 2.492
Classification and characterization of human endogenous retroviruses; mosaic forms are common 2.429
Human Endogenous Retrovirus type W distribution in the human genome: identification and characterization of a new set of proviral sequences in GRCh37/hg19 assembly 2.405
Contribution of type W human endogenous retroviruses to the human genome: Characterization of HERV-W proviral insertions and processed pseudogenes 2.397
Integration of SARS-CoV-2 RNA in infected human cells by retrotransposons: an unlikely hypothesis and old viral relationships 2.343
Improvement of the activity of the anti-HIV-1 integrase aptamer T30175 by introducing a modified thymidine into the loops 2.285
Inhibitory effect of 2,3,5,6-tetrafluoro-4-[4-(Aryl)-1H-1,2,3-triazol-1-yl]benzenesulfonamide derivatives on HIV reverse transcriptase associated rnase H activities 2.276
Identification and genomic characterization of HERV-K (HML-10) in human genome GRCh37/hg19 assembly 2.240
HERV-W group evolutionary history in non-human primates: Characterization of ERV-W orthologs in Catarrhini and related ERV groups in Platyrrhini 2.167
Discovery of dihydroxyindole-2-carboxylic acid derivatives as dual allosteric HIV-1 Integrase and Reverse Transcriptase associated Ribonuclease H inhibitors 2.057
Human endogenous retroviruses are ancient acquired elements still shaping innate immune responses 2.020
Targeting HIV-1 RNase H: N'-(2-Hydroxy-benzylidene)-3,4,5-Trihydroxybenzoylhydrazone as Selective Inhibitor Active against NNRTIs-Resistant Variants 2.015
HERV envelope proteins: Physiological role and pathogenic potential in cancer and autoimmunity 1.964
Type W Human Endogenous Retrovirus (HERV-W) Integrations and Their Mobilization by L1 Machinery: Contribution to the Human Transcriptome and Impact on the Host Physiopathology 1.951
Comprehensive Characterization of the Human Endogenous Retrovirus HERV-K(HML-6) Group: Overview of Structure, Phylogeny, and Contribution to the Human Genome 1.868
null 1.820
Pyrrolyl Pyrazoles as Non-Diketo Acid Inhibitors of the HIV-1 Ribonuclease H Function of Reverse Transcriptase 1.809
Antiretroviral activity of metal-chelating HIV-1 integrase inhibitors 1.801
The emerging field of human endogenous retroviruses: Understanding their physiological role and contribution to diseases 1.796
The traditional Chinese medicine plant Schisandra Chinensis as source of new HIV-1 reverse transcriptase inhibitor scaffolds effective also on non-nucleoside resistant reverse transcriptases 1.725
Human Endogenous Retrovirus type W characterization in genome assembly GRCh37/hg19: an innovative approach for human diseases investigation 1.643
Comprehensive Analysis of HERV Transcriptome in HIV+ Cells: Absence of HML2 Activation and General Downregulation of Individual HERV Loci 1.608
Identification and characterization of ERV-W-like sequences in Platyrrhini species provides new insights into the evolutionary history of ERV-W in primates 1.596
High-Throughput Sequencing is a Crucial Tool to Investigate the Contribution of Human Endogenous Retroviruses (HERVs) to Human Biology and Development 1.548
Identification and characterization of Type W Human Endogenous Retroviruses (HERV-W) in humans and comparative analysis of the group in non-human primates: new insights on HERV-W diffusion in Simiiformes and analysis of evolutionarily highly related sequences in New World Monkeys 1.499
Zika virus NS2A inhibits interferon signaling by degradation of STAT1 and STAT2 1.360
IDENTIFICATION AND BIOINFORMATICS CHARACTERIZATION OF 98 HERV-K(HML-2) CONTAINING PROVIRUSES IN THE HUMAN GENOME ASSEMBLY GRCh37/hg19 1.235
Recent and long-lasting infections: the need for avidity testing in HIV-1 infected subjects. 1.219
A human MMTV-like betaretrovirus linked to breast cancer has been present in humans at least since the Copper Age 1.207
Contribution of human retroviruses to disease development-A focus on the HIV- And HERV-cancer relationships and treatment strategies 1.177
INMI1 Zika Virus NS4B Antagonizes the Interferon Signaling by Suppressing STAT1 Phosphorylation 1.155
IDENTIFICATION AND GENOMIC CHARACTERIZATION OF HERV-K(HML-10) IN HUMAN GENOME GRCh37/hg19 ASSEMBLY 1.141
RNA-seq transcriptome analysis reveals long terminal repeat retrotransposon modulation in human peripheral blood mononuclear cells after in vivo lipopolysaccharide injection 1.094
Early Diffusion of SARS-CoV-2 Infection in the Inner Area of the Italian Sardinia Island 1.051
Quinolinonyl Non-Diketo Acid Derivatives as Inhibitors of HIV-1 Ribonuclease H and Polymerase Functions of Reverse Transcriptase 914
Retrotransposons as drivers of Mammalian brain evolution 883
Human endogenous retroviruses (HERVs) and mammalian apparent Ltrs retrotransposons (MALRs) are dynamically modulated in different stages of immunity 835
HERV‐K(HML7) integrations in the human genome: Comprehensive characterization and comparative analysis in non‐human primates 699
Genomic Snapshot of SARS-CoV-2 in Migrants Entering Through Mediterranean Sea Routes 688
Enhanced antitumoral activity of TLR7 agonists via activation of human endogenous retroviruses by HDAC inhibitors 658
Human Endogenous Retrovirus (HERV) Transcriptome Is Dynamically Modulated during SARS-CoV-2 Infection and Allows Discrimination of COVID-19 Clinical Stages 626
Identification, comprehensive characterization, and comparative genomics of the HERV-K(HML8) integrations in the human genome 625
Sennoside A, from the Traditional Chinese Medicine plant Rheum L., is a new reverse transcriptase inhibitor effective against HIV-1 replication 567
Diagnosi in vitro della Sclerosi Multipla 409
Prolonged activity of HERV-K(HML2) in Old World Monkeys accounts for recent integrations and novel recombinant variants 346
The impact of insularity on SARS-CoV-2 diffusion: Recapitulating three years of COVID-19 pandemic in the island of Sardinia 207
The central role of creatine and polyamines in fetal growth restriction 13
Meeting report: Seventh summer school on innovative approaches for identification of antiviral agents (IAAASS) 5
Totale 85.541
Categoria #
all - tutte 103.183
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 103.183


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020667 0 0 0 0 0 0 0 0 0 0 246 421
2020/202118.837 464 559 739 5.322 3.566 1.869 1.197 1.232 507 1.360 1.431 591
2021/20226.028 565 412 403 371 423 384 407 400 613 658 700 692
2022/202311.240 1.015 1.685 1.293 980 627 1.203 600 848 603 729 927 730
2023/20249.944 607 363 341 725 938 1.561 1.431 737 629 655 922 1.035
2024/202514.627 1.859 5.088 2.348 1.934 911 1.016 1.107 58 152 116 38 0
Totale 85.541